Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib vs Placebo with Paclitaxel/Carboplatin in Advanced NSCLC
NCT00795340Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cediranib in non-small cell lung cancer (NSCLC), sponsored by Canadian Cancer Trials Group. Started Feb 2009; status: completed.
02
Drugs
cediranib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00795340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795340.